$AVPT

AvePoint, Inc.

0
1
1
—
$710K
Brown Brian Michael
100%
See all $AVPT insider activity →
Low

AvePoint chief legal officer sells $141,100 in stock

AvePoint's CLO, Brian Michael Brown, sold 10,000 shares for $141,100 on September 30, 2026, under a 10b5-1 plan. AVPT stock has risen 54% in six months. Analysts from BMO, D.A. Davidson, Cantor Fitzgerald, and Stephens have issued positive ratings and price targets, citing strong growth prospects in AI-driven data management.

AvePoint’s ARR Grew 27%. Why Didn’t Its Adjusted Margin Follow?

AvePoint reported Q2 revenue of $124.5M, up 22%, and ARR of $465.1M, up 27%. However, adjusted operating margin fell to 16.3% from 18.4%, and gross margin declined to 73.1% from 74.0%. GAAP operating income rose to $10.2M, but adjusted profit growth lagged due to higher sales and marketing costs.

AVPT sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning AVPT (AvePoint, Inc.). Coverage has skewed bearish: 0 bullish, 1 neutral, and 1 bearish.

Recent AVPT coverage spans financial news, earnings and insider activity.

In the last 30 days, AVPT insiders filed 3 SEC Form 4 transactions — no purchases and 3 sales ($710K). The most active reporter was Brown Brian Michael, Chief Legal Officer, with 3 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving AVPT

AlphAI scores every news story that mentions AVPT with an AI model for sentiment and relevance, and aggregates insider trades from AvePoint, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AVPT

Score
$AVPTLow

AvePoint chief legal officer sells $141,100 in stock

AvePoint's CLO, Brian Michael Brown, sold 10,000 shares for $141,100 on September 30, 2026, under a 10b5-1 plan. AVPT stock has risen 54% in six months. Analysts from BMO, D.A. Davidson, Cantor Fitzgerald, and Stephens have issued positive ratings and price targets, citing strong growth prospects in AI-driven data management.

$NFLXMed

Here are Tuesday's biggest analyst calls of the day: Nvidia, AMD, Procter & Gamble, Meta & more

Analysts made several calls on Tuesday, including Goldman Sachs lowering Netflix's price target but maintaining a buy rating, Wells Fargo upgrading Cleveland-Cliffs, and Mizuho raising AMD's price target to $705. Other notable moves include upgrades for Skyworks Solutions, Dollar General, and Prosperity Bancshares, while new coverage was initiated on companies like AvePoint, Pasqal Holdings, and Standard Nuclear.

$AVPTMedAI 9/10

AvePoint (AVPT) Q2 2026 Earnings Call Transcript

AvePoint (AVPT) reported Q2 2026 revenue of $124.5M, up 22% YoY, with SaaS revenue $98.5M (79% of total). Total ARR was $465.1M (+27%), net new ARR $29.9M, and GAAP operating margin 8.2%. Full-year guidance: ARR $522.1M-$528.1M and revenue $508.5M-$512.5M. The company also spent $50M on share repurchases in Q2.

$AVPTHighAI 9/10

AvePoint lifts annual recurring revenue guidance after Q2

AvePoint reported Q2 2026 revenue of $124.5M and raised full-year annual recurring revenue guidance. SaaS revenue was $98.5M, up 27% y/y, and ARR ended at $465.1M, up 27%. Q3 revenue is forecast at $128.2M to $130.2M, and full-year ARR at $522.1M to $528.1M. The company cited demand for AI governance.

$AVPTHigh

AvePoint Announces Second Quarter 2026 Financial Results

AvePoint, Inc. (AVPT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 AvePoint Announces Second Quarter 2026 Financial Results Second quarter SaaS revenue of $98.5 million, representing 27% year-over-year growth, 26% on a constant currency basis Second quarter Total revenue of $124.5 million, representing 22% year-over-year growth, 21%

Related tickers